Streetbeat News

Revenues

BG

Bunge Global (NYSE:BG) received mixed analyst ratings with a shift towards a more cautious outlook, as evidenced by lowered price targets and a decrease in the average 12-month price target from $136.67 to $118. Analysts from Citigroup, Goldman Sachs, Baird, and Barclays adjusted their ratings and price targets, reflecting changes in market conditions and Bunge Global's performance. Despite a revenue decline of -15.11% over the past 3 months, Bunge Global maintains strong profitability indicators such as a net margin of 2.62%, ROE of 3.58%, and ROA of 1.47%, with a conservative debt-to-equity ratio of 0.58.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 12:00 pm

NYCB

Analyst ratings for New York Community (NYSE:NYCB) show a mix of views, with a recent trend towards neutrality. Over the last quarter, 7 analysts have provided ratings, with the majority being indifferent. The average 12-month price target has been adjusted to $9.07, down from $12.40, indicating a significant change in expectations. Analyst actions include lowering price targets and adjusting ratings, reflecting changing market dynamics and company performance. New York Community Bancorp Inc, the bank holding company, shows strong market positioning with a notable revenue growth rate but faces challenges in profitability and debt management.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 12:00 pm

EXTR

Extreme Networks (NASDAQ:EXTR) has received mixed analyst ratings over the past three months, with a recent shift towards a more cautious outlook. The average 12-month price target has been lowered to $19.12 from $22.50, reflecting a 15.02% decrease. Analysts from Needham and UBS have adjusted their ratings and price targets, indicating a varied perception of the company's future performance. Despite this, Extreme Networks has shown strong financial performance, with significant revenue growth, high net margin, and robust ROE and ROA, although its debt-to-equity ratio suggests potential financial challenges.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 12:00 pm

DGX

Quest Diagnostics forecasts its fiscal 2024 revenues to be between $9.35B and $9.45B with an adjusted EPS of $8.60 to $8.90, slightly below the consensus expectations of $9.38B in revenue and $8.97 in EPS.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 11:56 am

FLWS

1-800-FLOWERS.COM (FLWS) has revised its FY24 revenue outlook downwards, now expecting a decline of 7%-9%, due to softer than anticipated revenue improvement. However, the company maintains its Adjusted EBITDA and Free Cash Flow expectations, citing improvements in gross profit margin and expense optimization efforts as mitigating factors.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 11:56 am

THR

Thermon Group Holdings (NYSE:THR) reported Q3 adjusted EPS of $0.59, surpassing the $0.50 estimate, and sales of $136.43M, exceeding the $129.18M estimate. This represents an 18% EPS beat and a 5.61% sales beat, with year-over-year growth of 13.46% in earnings and 11.72% in sales.

Portfolio Pulse from saritha@benzinga.com

February 01, 2024 | 11:51 am

GOOS

Canada Goose projects its Q4 total revenue to be between C$310M and C$330M, surpassing the estimated C$301.035M. Additionally, its non-IFRS adjusted EPS is expected to range from C$0.02 to C$0.13, compared to the estimated C$0.08.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 11:48 am

GOOS

Canada Goose Holdings (GOOS) reported Q3 2024 adjusted EPS of C$1.37, meeting analyst estimates, but missed sales forecasts with C$609.90M versus the expected C$620.05M. This represents a 42.05% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 11:46 am

DOV

Dover projects its 2024 GAAP EPS to be between $7.90 and $8.10, with an adjusted EPS of $8.95 to $9.15, which is below the consensus estimate of $9.24. The company anticipates revenue growth of 2%-4%, with 1%-3% of this being organic growth.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 11:35 am

DLTR

Dollar Tree Inc. (NASDAQ:DLTR) and WanaBana are facing a lawsuit filed by a North Carolina family, alleging their children suffered lead poisoning from WanaBana applesauce pouches sold by Dollar Tree. The lawsuit claims the companies knew of the product's dangers. The CDC has received 404 reports of possible lead poisoning from the pouches across 43 states. This legal issue arises amid scrutiny of Dollar Tree's product safety measures and could impact its reputation and financial performance.

Portfolio Pulse from Benzinga Neuro

February 01, 2024 | 11:33 am